Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Down 62.6% in January

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the target of a large decrease in short interest in January. As of January 15th, there was short interest totalling 10,400 shares, a decrease of 62.6% from the December 31st total of 27,800 shares. Based on an average trading volume of 273,300 shares, the days-to-cover ratio is currently 0.0 days.

Biodexa Pharmaceuticals Trading Down 1.5 %

BDRX traded down $0.07 during trading on Tuesday, hitting $4.25. The company’s stock had a trading volume of 9,430 shares, compared to its average volume of 14,978. The stock has a 50 day moving average price of $4.48. Biodexa Pharmaceuticals has a one year low of $3.50 and a one year high of $74.00.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.